164 related articles for article (PubMed ID: 32167927)
1. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples.
Kitano M; Rahbari R; Patterson EE; Steinberg SM; Prasad NB; Wang Y; Zeiger MA; Kebebew E
Thyroid; 2012 Mar; 22(3):285-91. PubMed ID: 22304369
[TBL] [Abstract][Full Text] [Related]
3. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
4. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T
Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.
Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H
Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206
[TBL] [Abstract][Full Text] [Related]
7. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
Panebianco F; Mazzanti C; Tomei S; Aretini P; Franceschi S; Lessi F; Di Coscio G; Bevilacqua G; Marchetti I
BMC Cancer; 2015 Nov; 15():918. PubMed ID: 26581891
[TBL] [Abstract][Full Text] [Related]
8. Fine-Needle Aspiration Biopsy as a Preoperative Procedure in Patients with Malignancy in Solitary and Multiple Thyroid Nodules.
Kaliszewski K; Diakowska D; Wojtczak B; Strutyńska-Karpińska M; Domosławski P; Sutkowski K; Głód M; Balcerzak W; Forkasiewicz Z; Łukieńczuk T
PLoS One; 2016; 11(1):e0146883. PubMed ID: 26784518
[TBL] [Abstract][Full Text] [Related]
9. Expression of micro-ribonucleic acids in thyroid nodules and serum to discriminate between follicular adenoma and cancer in patients with a fine needle aspiration biopsy classified as suspicious for follicular neoplasm: A preliminary study.
Świrta JS; Wątor G; Seweryn M; Kapusta P; Barczyński M; Wołkow P
Adv Clin Exp Med; 2023 Sep; 32(9):997-1007. PubMed ID: 36897102
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine-needle aspiration samples.
Zhang Y; Zhong Q; Chen X; Fang J; Huang Z
Tumour Biol; 2014 Sep; 35(9):9343-53. PubMed ID: 24943685
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAs.
Kitano M; Rahbari R; Patterson EE; Xiong Y; Prasad NB; Wang Y; Zeiger MA; Kebebew E
Ann Surg Oncol; 2011 Nov; 18(12):3443-52. PubMed ID: 21553140
[TBL] [Abstract][Full Text] [Related]
12. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
15. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses.
Yang F; Zhang H; Leng X; Hao F; Wang L
Br J Biomed Sci; 2018 Jan; 75(1):43-45. PubMed ID: 28937915
[No Abstract] [Full Text] [Related]
16. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.
Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178
[TBL] [Abstract][Full Text] [Related]
17. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
18. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
[TBL] [Abstract][Full Text] [Related]
19. A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears.
Fassina A; Cappellesso R; Simonato F; Siri M; Ventura L; Tosato F; Busund LT; Pelizzo MR; Fassan M
Cancer Cytopathol; 2014 Apr; 122(4):274-81. PubMed ID: 24327568
[TBL] [Abstract][Full Text] [Related]
20. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
